A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India (DCGI), the defence ministry said on......
The first batch of anti-COVID oral drug 2-DG, developed by the Defence Research and Development Organisation, was released on Monday by Defence Minister Rajnath Singh and Health Minister Harsh......
Drug major Dr Reddy's Laboratories on Monday announced the commercial launch of COVID-19 treatment drug, 2-deoxy-D-glucose (2-DG), at a maximum retail price of Rs 990 per sachet. IMAGE:......
Tired of waiting for hikes and government stipends, research scholars took to the streets against the Union government’s neglect towards raising the fellowship amount in the national capital......
An anti-COVID oral drug developed by the Defence Research and Development Organisation has been approved by the Drugs Controller General of India for emergency use as an adjunct therapy in moderate......